Placental expression of eNOS, iNOS and the major protein components of caveolae in women with pre-eclampsia

Ghabour, 1995, Immunohistochemical characterization of placental nitric oxide synthase expression in preeclampsia, Am J Obstet Gynecol, 173, 687, 10.1016/0002-9378(95)90324-0

Alderton, 2001, Nitric oxide synthases: structure, function and inhibition, Biochem J, 357, 593, 10.1042/0264-6021:3570593

Parton, 1996, Caveolae and caveolins, Curr Opin Cell Biol, 8, 542, 10.1016/S0955-0674(96)80033-0

Briand, 2011, Cavin proteins: new players in the caveolae field, Biochimie, 93, 71, 10.1016/j.biochi.2010.03.022

Liu, 2008, A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization, J Biol Chem, 283, 4314, 10.1074/jbc.M707890200

Mathew, 2011, Cell-specific dual role of caveolin-1 in pulmonary hypertension, Pulm Med, 2011, 573432, 10.1155/2011/573432

Byrne, 2001, Immunocytochemical localization of a caveolin-1 isoform in human term extra-embryonic membranes using confocal laser scanning microscopy: implications for the complexity of the materno-fetal junction, Placenta, 22, 499, 10.1053/plac.2001.0697

Lyden, 2002, The endothelium but not the syncytiotrophoblast of human placenta expresses caveolae, Placenta, 23, 640, 10.1053/plac.2002.0847

Linton, 2003, Caveolae and caveolin-1 in human term villous trophoblast, Placenta, 24, 745, 10.1016/S0143-4004(03)00106-1

Ushio-Fukai, 2006, Caveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle, Hypertension, 48, 797, 10.1161/01.HYP.0000242907.70697.5d

Mistry, 2008, Reduced selenium concentrations and glutathione peroxidase activity in pre-eclamptic pregnancies, Hypertension, 52, 881, 10.1161/HYPERTENSIONAHA.108.116103

Brown, 2001, The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the international society for the study of hypertension in pregnancy (ISSHP), Hypertens Pregnancy, 20, IX, 10.3109/10641950109152635

Mistry, 2011, Novel expression and regulation of voltage-dependent potassium channels in placentas from women with preeclampsia, Hypertension, 58, 497, 10.1161/HYPERTENSIONAHA.111.173740

Dotsch, 2001, Increase of endothelial nitric oxide synthase and endothelin-1 mRNA expression in human placenta during gestation, Eur J Obstet Gynecol Reprod Biol, 97, 163, 10.1016/S0301-2115(00)00532-7

Corthorn, 2006, Expression of kallikrein, bradykinin b2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta, Endocrine, 29, 491, 10.1385/ENDO:29:3:491

Matsubara, 2001, Immuno-electron microscopic localization of endothelial nitric oxide synthase in human placental terminal villous trophoblasts-normal and pre-eclamptic pregnancy, Placenta, 22, 782, 10.1053/plac.2001.0718

Mistry, 2013, The placental renin-angiotensin system and oxidative stress in pre-eclampsia, Placenta, 34, 182, 10.1016/j.placenta.2012.11.027

Chen, 2014, Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species, Free Radic Biol Med, 73, 201, 10.1016/j.freeradbiomed.2014.04.029

Lobysheva, 2011, Moderate caveolin-1 downregulation prevents NADPH oxidase-dependent endothelial nitric oxide synthase uncoupling by angiotensin II in endothelial cells, Arterioscler Thromb Vasc Biol, 31, 2098, 10.1161/ATVBAHA.111.230623

Layne, 2011, Caveolae: a regulatory platform for nutritional modulation of inflammatory diseases, J Nutr Biochem, 22, 807, 10.1016/j.jnutbio.2010.09.013

Williams, 2010, Expression of AT1R, AT2R and AT4R and their roles in extravillous trophoblast invasion in the human, Placenta, 31, 448, 10.1016/j.placenta.2010.02.014

Frank, 2004, Genetic ablation of caveolin-1 confers protection against atherosclerosis, Arterioscler Thromb Vasc Biol, 24, 98, 10.1161/01.ATV.0000101182.89118.E5